Dr. Robert D. Williams, M.D. (Emeritus)
Dr. Williams’ patients are now seen by Dr. Sulkowski.
Dr. Williams has retired from clinical practice at The Taustine Eye Center. He is now semi-retired living in the Puget Sound area of Washington state. He is still serving as a consultant in developing new glaucoma medicines and treatments.
Dr. Robert Williams was the founder and director of both the Glaucoma Center and the Clinical Research Center at the Taustine Eye Center. After practicing general ophthalmology for more than a decade, he returned to the University of Louisville in 1991 to serve a fellowship in glaucoma. There he studied the latest techniques for diagnosing and treating glaucoma and participated in research into the treatment of glaucoma. From 1991 to his retirement his practice was limited to the care of people with glaucoma.
As a member of the prestigious American Glaucoma Society (AGS) and of the Association for Research in Vision and Ophthalmology (ARVO) he continues to study the most current thinking about glaucoma and its treatment. He has presented papers of his original research at both of these organizations.
In 1994 he joined the Taustine Eye Center. He was an Associate Professor of Ophthalmology at the University of Louisville. A popular teacher, he spent a considerable amount teaching general ophthalmologists about the latest advances in glaucoma.
As the Director of Clincial Research at the Taustine Eye Center and the founder of the Center for Clinical Research, he has participated in the development of many new medications for glaucoma. He performed research and served as a consultant for many of the ophthalmic pharmaceutical companies including Merck, Allergan, Alcon, Pfizer, Otsuka, Senju Santen, Aerie, Inspire, Sirion and Insite.
Dr. Williams felt that glaucoma therapy must be tailored to the individual. Therapy must take into account the lifestyle, needs and desires of the patients. He encouraged the active participation of patients in designing a treatment regimen that suited them while insuring that they protect their vision from damage.